Interestingly, we discovered that silencing GIT1 in ER(−) breast cancer cells resulted in an expanded ALDH1+ population and enhanced clonogenic capacity, indicating that GIT1 is a critical negative modulator of ALDH1. Here, GIT1 is linked to breast carcinoma.